All Access Pass - 3 FREE Months!
Institutional email required, no credit card necessary.
Genetic Myopathies (Inherited Myopathies)

Genetic Myopathies (Inherited Myopathies)

Start 1-Month Free Access!
No institutional email? Start your 1 week free trial, now!
genetic myopathies (Inherited muscle diseases, Muscular dystrophies)
Muscle histology: Review
  • Epimysium envelopes the muscle.
  • Perimysium divides the muscle into fascicles.
  • Endomysium lies within the muscle fascicle: it comprises a loose areolar connective tissue that maintains the extracellular environment for proper muscle cell functioning.
Muscle fascicle histology: Review
  • The muscle cell is covered in endomysium.
  • The cell has many nuclei.
  • Dot-like myofibrils constitute the muscle cell milieu.
Muscle Cell Physiology: Review/Pathology Introduction
  • Proteins stabilize myofibrils to the muscle cell and can be linked to well-defined related myopathies.
  • Each Myofibril includes a Z-disk, which transects an I Band, flanked by A Bands.
  • Repeating light and dark bands gives muscle fibers a striated appearance.
  • Desmin filaments encircle the Z disks.
  • Desmin-related myopathy (DRM) is an inherited disease which results in disorganized and weak skeletal muscle fibers. DRM can be fatal, as it also affects cardiac and smooth muscles.
  • Plectin links the desmin filaments.
  • Alpha-B-crystallin (a heat shock protein) protects desmin from stress-induced damange. Together: desmin, plectin, and alpha-B-crystallin constitute a Z-disk protection network.
  • Dystrophin-associated glycoprotein complex (DAGC) comprises:
    • Dystroglycan subcomplex, which links dystrophin to laminin, a key external lamina protein (called laminin-2 in skeletal muscle, which has an associated myopathic syndrome).
    • Sarcoglycan subcomplex, which, when defective can cause sarcoglycanopathies – a similar manifestation of weakness as those from dystrophinopathies – and are a common cause of limb-girdle muscular dystrophy.
–Dystrophin stabilizes the sarcolemma during muscle contraction. When pathologic, it produces the dystrophinopathies (eg, Duchenne Muscular Dystrophy, Becker Muscular Dystrophy).
  • Syntrophins are recruited to the sarcolemma and manage the assembly of other proteins.
  • Dystrobrevins link desmin to dystrophin and syntrophin.
Muscular Dystrophies
Dystrophinopathies (Duchenne, Becker):
We include a pathological slide of a muscle from an individual with Duchenne muscular dystrophy (DMD).
Overview
  • X-linked, Recessive form of muscular dystrophy that affects boys and occurs from a genetic mutation that prevents the synthesis of dystrophin.
  • Muscle is replaced with fatty and fibrous connective tissue, which presents with pseudohypertrophic muscles: muscles that are enlarged from fat and connect tissue (not muscle).
  • Duchenne Muscular Dystrophy is a severe dystrophinopathy wherein children are non-ambulatory at ~ age 13 – pseudohypertrophy of calf muscles is a notable clinical finding.
  • Becker Muscular Dystrophy is a less severe dystrophinopathy in that patients aren't non-ambulatory until ~ age 40.
  • As a helpful mnemonic add the treatment adage that the goal of corticosteroids is to: Make Duchenne boys into Becker men.
  • Most severe form
  • Manifests in childhood with proximal weakness (especially calf hypertrophy)
  • Loss of ambulation ~ age 13
  • Less severe form
  • Manifests in early teens
  • Loss of ambulation ~ age 40
Genetic & Diagnostic Characteristics of Duchenne & Becker Muscular Dystrophies
  • Genetics
    • X-Linked, Recessive
    • Dystrophin gene mutation that leads to reduction/absence of dystrophin protein with resultant sarcolemma damage
  • Diagnosis: Elevated CK (~20,000), Dystrophin Gene Deletion
  • Treatment: Corticosteroids
Myotonic Dystrophy, Type 1
  • Characterized by myotonia (eg, inability to release a grip) [relaxes with repetition vs. paramyotonia which worsens with repetition]. Responds to Mexilitine.
  • Weakness of lower extremities, hands, neck, and face
  • Additional systemic features
    • Cataracts
    • Cardiac conduction defects
    • Early Frontal balding
Myotonic Dystrophy, Type 2
  • Myotonia
  • Weakness of neck, shoulders, elbows, and hips.
Genetic & Diagnostic Characteristics of the Myotonic Dystrophies
  • Autosomal Dominant
  • Anticpiation in DM-1 with the DMPK gene [CTG Trinucleotide repeats]
  • EMG findings of myotonic discharges.
Oculopharyngeal Muscular Dystrophy
  • Ptosis and dysphagia
  • Onset > age 40
  • Genetics
    • Autosomal Dominant
    • PABPN1 gene
  • Asymmetric facial and scapular muscles (scapular winging) and humeral (upper arm) atrophy: difficulty whistling, closing eyes, throwing ball
  • Symptoms appear in adolescence
  • Genetics
    • Autosomal Dominant
    • D4Z4 contraction on chromosome 4q35 (Majority of genetic cause)
Limb-Girdle Muscular Dystrophies
  • Present with proximal weakness at any age, manifesting with waddling gait, scapular winging, possible joint contractures.
  • Cardiomyopathy or respiratory compromise are key potential complications
  • Diagnosis: Elevated CK, genetic testing, and immunohistochemical muscle biopsy staining
  • Genetics
    • Various genetic pathologies involving muscle cell proteins: sarcolemmal, cytosolic, nuclear envelope.
    • Notable forms: -LMNA gene [lamin A/C], CAPN3 gene [calpainopathy], DYSF gene [dysferlinopathy], SGC genes [sarcoglycanopathies]
  • Skeletal & cardiac muscle are affected
  • Early contractures (joint deformities)
  • Upper arm/lower leg wasting
  • Genetics
    • X-linked
    • EMD gene (most commonly), which forms emerin: a nuclear envelope protein.
    • LMNA gene (less commonly), which forms lamin A/C
Congenital Myopathies
Central Core Myopathy
  • Floppy infants
  • Associated skeletal abnormalities: scoliosis, hip dislocation, joint deformities
  • Risk of malignant hyperthermia from anesthetics
  • Pathology: microscopic cores in the center of muscle fibers
  • Genetics
    • Autosomal Dominant
    • RYR1 gene for the Ryanodine Receptor 1, which forms a channel that releases calcium from muscle cells
Nemaline Rod Myopathy
  • Infant onset is most common – Hypotonia and poor respiration
  • Adults - Proximal weakness and skeletal abnormalities (scoliosis and contractures)
  • Abnormal clumps of threaded filaments (hence: "nema" for "thread") in muscle fibers that can look like rods.
  • Genetics
    • Autosomal recessive.
    • Mutations in sarcommeric proteins.
Metabolic Myopathies
Pompe Disease (Acid Maltase Deficiency)
  • Infantile-onset (classic vs non-classic): myopathy, hypotonia, hepatomegaly, congenital heart defects
  • Late-onset: Progressive weakness and respiratory failure.
  • Genetics
    • Autosomal recessive.
    • GAA gene for acid alpha-glucosidase (acid maltase), which is key for break-down of glycogen to glucose within lysosomes.
McArdle Disease (Glycogen Storage Disease Type V)
  • Exercise-induced Pain/Cramps/Fatigue, which alleviates with rest ("Second Wind" phenomenon).
  • Severe forms cause rhabdomyolysis with myoglobinuria.
  • Genetics
    • PYCM gene for myophosphorylase, which is specific to muscle. It breaks down glycogen to glucose-1-phosphate.
  • Forearm ischemic exercise test: lactate [no change], ammonia [normal increase].
  • Muscle biopsy: lack of phosphorylase. Subsarcolemmal glycogen deposits.
  • Treatment: Enzyme replacement therapy, Avoidance of maximal exercise, High-protein and low carbohydrate diet.
Carnitine Palmitoyltransferase Deficiency 2
  • Lipid metabolism disorder that prevents the body from using fat for energy during periods of fasting.
  • Carnitine Palmitoyltransferase 2 (CPT2) is involved in inner mitochondrial membrane transport – deficiency comprises mitochondrial fatty oxidation.
  • Three forms of the disorder (from most severe to least): lethal neonatal, infantile hepato-cardio-muscle, and myopathic.
    • Myopathic form causes: myalgias and rhabdomyolysis.
  • Genetics
    • CPT2 gene mutation involving fatty acid oxidation within mitochondria.
    • Long-chain fatty acids must attach to carnitine to enter mitochondria. Once inside, CPT2 removes carnitine for fatty oxidation – without CPT2, fatty acids can't be used for energy.
  • Treatment: High carbohydrate, Low fat diet.
Channelopathies
Myotonia Congenita (Thomsen & Becker Disease)
  • Abnormal muscle excitability that is NON-dystrophic, exacerbated in cold.
  • Muscle stiffness. Myotonia (eg, inability to release a grip) [relaxes with repetition vs. paramyotonia which worsens with repetition]. Responds to Mexilitine.
  • Genetics
    • CLCN1 gene – chloride channelopathy, SCN4A – sodium channelopathy
    • Thomsen – Autosomal Dominant. Becker – Autosomal Recessive.
Familial Periodic Paralysis
  • Flaccid weakness in the setting of hypokalemia or hyperkalemia that can last hours to days.
  • Triggered by intense exercise, large carbohydrate meal, viral infection, or medications.
  • Genetics
    • Autosomal Dominant
    • CACNA1S gene – calcium channelopathy, SCN4A – sodium channelopathy
  • Don't forget other potential causes of episodic weakness: Myasthenia Gravis, Lambert-Eaton, Thryotoxicosis, and Metabolic Derangement – calcium, phosphorous, magnesium, sodium.
  • Maternally-inherited
  • Ragged red fibers / Subsarcolemmal accumulation of abnormal mitochondria